세계의 세포 증식 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)
Global Cell Expansion Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
상품코드:1547583
리서치사:Value Market Research
발행일:2024년 07월
페이지 정보:영문 181 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세포 증식 시장의 세계 수요는 2023년 241억 5,000만 달러에서 2032년 약 325억 5,000만 달러 규모에 도달할 것으로 추정되며, 2024-2032년의 조사 기간 동안 3.37%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.
세포 증식은 세포의 증식 및 성장을 통해 배양된 세포의 수를 증가시키는 것으로, 일반적으로 생의학 및 생명공학 분야에서 사용됩니다. 여기에는 세포의 생존력과 기능을 유지하면서 세포의 분열과 복제를 자극하는 데 필요한 영양소, 성장 인자 및 환경 조건을 세포에 제공하는 것이 포함됩니다. 세포치료, 조직공학, 약물 스크리닝, 조사 연구 등 다양한 목적을 위해 충분한 양의 세포를 생산하는 데 필수적입니다.
시장 역학
세포 증식 시장은 만성질환의 유행, 세포를 이용한 연구의 발전, 재생의료 및 맞춤치료에 대한 수요 증가 등의 요인에 의해 주도되고 있습니다. 암, 당뇨병과 같은 만성 질환은 혁신적인 치료법이 필요하며, 세포 배양은 세포 기반 치료법 개발에 필수적입니다. 줄기세포 및 기타 세포에 초점을 맞춘 연구 활동의 급증은 치료용 세포 생산의 효율성과 확장성을 향상시켜 상당한 기술적 진보를 가져왔습니다. 재생의료는 손상된 조직과 장기를 복구하거나 대체하는 것을 목표로 하며, 충분한 기능적 세포를 공급하기 위해 세포 증식에 크게 의존하고 있습니다. 또한, 바이오의약품 연구개발에 대한 자금과 투자 증가는 시장을 주도하고 있으며, 세포 기반 치료법의 추가 혁신과 적용을 가능하게 하고 있습니다. 그러나 확장성 문제와 규제 장벽은 향후 몇 년동안 시장 성장에 걸림돌이 될 수 있습니다.
이 조사 보고서는 Porter's Five Forces 모델, 시장 매력도 분석, 밸류체인 분석을 다룹니다. 이러한 도구는 산업 구조를 명확하게 파악하고 세계 수준에서 경쟁의 매력을 평가하는 데 도움이 될 수 있습니다. 또한 이러한 도구는 세계의 세포 증식 시장에서 각 부문을 종합적으로 평가할 수 있습니다. 세포 증식 산업의 성장과 동향은 이 조사에 대한 전체적인 접근 방식을 제공합니다.
시장 세분화
세포 증식 시장 보고서의 이 섹션에서는 국가 및 지역별 부문에 대한 자세한 데이터를 제공하여 전략 담당자가 각 제품 또는 서비스의 타겟층을 파악하여 향후 비즈니스 기회를 파악할 수 있도록 지원합니다.
제품별
소모품(시약, 배지, 혈청, 기타 소모품)
배양 플라스크 및 액세서리(조직 배양 플라스크, 생물 반응기 액세서리, 기타 배양 플라스크 및 액세서리)
The global demand for Cell Expansion Market is presumed to reach the market size of nearly USD 32.55 Billion by 2032 from USD 24.15 Billion in 2023 with a CAGR of 3.37% under the study period 2024-2032.
Cell expansion increases cell number in a culture through cell proliferation or growth, typically for biomedical and biotechnological applications. It involves providing cells with the necessary nutrients, growth factors, and environmental conditions to stimulate their division and replication while maintaining their viability and functionality. It is essential for producing sufficient quantities of cells for various purposes, such as cell therapy, tissue engineering, drug screening, and research studies.
MARKET DYNAMICS
The cell expansion market is driven by factors such as the prevalence of chronic diseases, advancements in cell-based research, and the growing demand for regenerative medicine and personalized therapies. Chronic diseases, such as cancer & diabetes, require innovative treatment approaches, with cell expansion crucial in developing cell-based therapies. The surge in research activities focusing on stem cells and other cell types has led to significant technological advancements, improving the efficiency and scalability of producing therapeutic cells. Regenerative medicine aims to repair or replace damaged tissues & organs and relies heavily on cell expansion to provide sufficient functional cells. Additionally, increased funding and investment in biopharmaceutical research and development drive the market, enabling further innovation and application of cell-based therapies. However, scalability issues and regulatory hurdles may hinder the market growth in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cell Expansion. The growth and trends of Cell Expansion industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Cell Expansion market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
Consumables (Reagents, Media, & Serum, Other Consumables)
Culture Flasks and Accessories (Tissue Culture Flasks, Bioreactor Accessories, Other Culture Flasks and Accessories)
This section covers the regional outlook, which accentuates current and future demand for the Cell Expansion market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Expansion market include Thermo Fisher Scientific Inc., GE Healthcare, Corning Incorporated, Merck KGaA, Miltenyi Biotec, BD (Becton, Dickinson And Company), Terumo BCT Inc., Sartorius AG, Takara Bio Inc., Trinova Biochem GmbH, Upcyte Technologies GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.3 Market Attractiveness Analysis By Application
3.7.4 Market Attractiveness Analysis By End-use
3.7.5 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL CELL EXPANSION MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Consumables (Reagents, Media, & Serum, Other Consumables) Historic and Forecast Sales By Regions
5.4. Culture Flasks and Accessories (Tissue Culture Flasks, Bioreactor Accessories, Other Culture Flasks and Accessories) Historic and Forecast Sales By Regions
5.5. Instruments (Automated Cell Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Other Instruments) Historic and Forecast Sales By Regions
6. GLOBAL CELL EXPANSION MARKET ANALYSIS BY CELL TYPE
6.1. Overview By Cell Type
6.2. Historical and Forecast Data Analysis By Cell Type
6.3. Mammalian (Human (Stem Cells (SCs), Adult SCs, Embryonic SCs, Induced Pluripotent SCs, Differentiated Cells), Animal) Historic and Forecast Sales By Regions
6.4. Microbial Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions
7. GLOBAL CELL EXPANSION MARKET ANALYSIS BY APPLICATION
7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Biopharmaceuticals Historic and Forecast Sales By Regions
7.4. Tissue Culture & Engineering Historic and Forecast Sales By Regions
7.5. Vaccine Production Historic and Forecast Sales By Regions
7.6. Drug Development Historic and Forecast Sales By Regions
7.7. Gene Therapy Historic and Forecast Sales By Regions
7.8. Cancer Research Historic and Forecast Sales By Regions
7.9. Stem Cell Research Historic and Forecast Sales By Regions
7.10. Others Historic and Forecast Sales By Regions
8. GLOBAL CELL EXPANSION MARKET ANALYSIS BY END-USE
8.1. Overview By End-use
8.2. Historical and Forecast Data Analysis By End-use
8.3. Biopharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
8.4. Research Institutes Historic and Forecast Sales By Regions
8.5. Cell Banks Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions
9. GLOBAL CELL EXPANSION MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
9.3.1 Overview, Historic and Forecast Data Sales Analysis
9.3.2 North America By Segment Sales Analysis
9.3.3 North America By Country Sales Analysis
9.3.4 United States Sales Analysis
9.3.5 Canada Sales Analysis
9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1 Overview, Historic and Forecast Data Sales Analysis
9.4.2 Europe By Segment Sales Analysis
9.4.3 Europe By Country Sales Analysis
9.4.4 United Kingdom Sales Analysis
9.4.5 France Sales Analysis
9.4.6 Germany Sales Analysis
9.4.7 Italy Sales Analysis
9.4.8 Russia Sales Analysis
9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1 Overview, Historic and Forecast Data Sales Analysis
9.5.2 Asia Pacific By Segment Sales Analysis
9.5.3 Asia Pacific By Country Sales Analysis
9.5.4 China Sales Analysis
9.5.5 India Sales Analysis
9.5.6 Japan Sales Analysis
9.5.7 South Korea Sales Analysis
9.5.8 Australia Sales Analysis
9.5.9 South East Asia Sales Analysis
9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1 Overview, Historic and Forecast Data Sales Analysis
9.6.2 Latin America By Segment Sales Analysis
9.6.3 Latin America By Country Sales Analysis
9.6.4 Brazil Sales Analysis
9.6.5 Argentina Sales Analysis
9.6.6 Peru Sales Analysis
9.6.7 Chile Sales Analysis
9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1 Overview, Historic and Forecast Data Sales Analysis
9.7.2 Middle East & Africa By Segment Sales Analysis
9.7.3 Middle East & Africa By Country Sales Analysis
9.7.4 Saudi Arabia Sales Analysis
9.7.5 UAE Sales Analysis
9.7.6 Israel Sales Analysis
9.7.7 South Africa Sales Analysis
9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE CELL EXPANSION COMPANIES
10.1. Cell Expansion Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11. COMPANY PROFILES OF CELL EXPANSION INDUSTRY
11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific Inc.
11.3.1 Company Overview
11.3.2 Company Revenue
11.3.3 Products
11.3.4 Recent Developments
11.4. GE Healthcare
11.4.1 Company Overview
11.4.2 Company Revenue
11.4.3 Products
11.4.4 Recent Developments
11.5. Corning Incorporated
11.5.1 Company Overview
11.5.2 Company Revenue
11.5.3 Products
11.5.4 Recent Developments
11.6. Merck KGaA
11.6.1 Company Overview
11.6.2 Company Revenue
11.6.3 Products
11.6.4 Recent Developments
11.7. Miltenyi Biotec
11.7.1 Company Overview
11.7.2 Company Revenue
11.7.3 Products
11.7.4 Recent Developments
11.8. BD (Becton, Dickinson And Company)
11.8.1 Company Overview
11.8.2 Company Revenue
11.8.3 Products
11.8.4 Recent Developments
11.9. Upcyte Technologies GmbH
11.9.1 Company Overview
11.9.2 Company Revenue
11.9.3 Products
11.9.4 Recent Developments
11.10. Terumo BCT Inc.
11.10.1 Company Overview
11.10.2 Company Revenue
11.10.3 Products
11.10.4 Recent Developments
11.11. Sartorius AG
11.11.1 Company Overview
11.11.2 Company Revenue
11.11.3 Products
11.11.4 Recent Developments
11.12. Takara Bio Inc.
11.12.1 Company Overview
11.12.2 Company Revenue
11.12.3 Products
11.12.4 Recent Developments
11.13. Trinova Biochem GmbH
11.13.1 Company Overview
11.13.2 Company Revenue
11.13.3 Products
11.13.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
